WCM Investment Management
PTCT icon

WCM Investment Management’s PTC Therapeutics PTCT Stock Holding History

WCM Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.65M Sell
93,799
-888
-0.9% -$64.1K 0.01% 168
2026
Q1 		$6.22M Sell
94,687
-15,580
-14% -$1.1M 0.01% 176
2025
Q4 		$8.4M Sell
110,267
-36,798
-25% -$2.67M 0.02% 159
2025
Q3 		$8.92M Buy
+147,065
New +$7.66M 0.02% 147

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

WCM Investment Management's PTCT Position: Q2 2026 in Review

WCM Investment Management reduced its PTC Therapeutics (PTCT) stake by 0.94% in Q2 2026, selling an estimated $64.1K and leaving 93,799 shares worth $7.65M. The position accounts for 0.01% of the portfolio, ranked #168.

WCM Investment Management first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.92M in Q3 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • WCM Investment Management held 93,799 shares of PTC Therapeutics worth $7.65M as of Q2 2026.
  • WCM Investment Management sold 888 PTC Therapeutics shares in Q2 2026, an estimated $64.1K.
  • PTC Therapeutics made up 0.01% of WCM Investment Management's portfolio in Q2 2026, its #168 holding.
  • WCM Investment Management first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • WCM Investment Management's PTC Therapeutics position peaked at $8.92M in Q3 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.